- ProPhase Labs (PRPH, Financial) receives a 180-day extension from Nasdaq to meet the $1 minimum bid price requirement.
- The company needs to achieve a closing bid price of at least $1.00 per share for 10 consecutive business days by December 22, 2025.
- If compliance is not achieved, PRPH risks delisting from Nasdaq.
ProPhase Labs, Inc. (PRPH) has been granted an additional 180-day extension by Nasdaq to regain compliance with the minimum bid price requirement of $1.00 per share. This extension was awarded following the company's inability to meet this requirement within the initial 180-day period that ended on June 24, 2025.
The company must now achieve a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days before the new deadline of December 22, 2025, to maintain its Nasdaq listing. Failure to do so will result in a written notification of delisting procedures from Nasdaq, which may impact the liquidity and institutional ownership of PRPH shares.
The extension was granted as ProPhase meets all other Nasdaq Capital Market initial listing requirements except for the bid price. Despite the current non-compliance, the company asserts that the notice does not affect its business operations, SEC reporting requirements, or contractual obligations.
